Multidisciplinary Journal of Science and Technology

HORMONE-GENETIC MECHANISMS OF METABOLIC-RELATED FATTY LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE. LITERATURE REVIEW

Yunusova Dilfuza

Andijon davlat tibbiyot instituti Normal fiziologiya kafedrasi assistenti.

Ravzatov Jasurbek

Andijon davlat tibbiyot instituti Oilaviy shifokorlar tayyorlash kafedrasi PhD, dotsenti

Keywords: metabolik bog‘liq yog‘li jigar kasalligi, metabolik assotsirlangan jigar steatoz kasalligi, reproduktiv yosh, jinsiy gormonlar, SHBG, CYP19A1, UGT2B15, UGT2B17, polikistoz tuxumdonlar sindromi, insulinrezistentlik.

---

Abstract

Metabolic fatty liver disease is one of the most pressing problems of modern hepatology and metabolic medicine. In addition to insulin resistance, visceral obesity, dyslipidemia, and chronic low-grade inflammation, hormonal imbalance and genetic factors also play an important role in the formation of this disease. Especially in women of reproductive age, genes related to estrogens, androgens, sex hormone binding globulin, the aromatase system, and steroid metabolism are inextricably linked to hepatic steatosis and its stages of exacerbation. This literature review analyzes the modern definition of metabolic fatty liver disease, hormonal characteristics observed in women, its association with polycystic ovary syndrome, the possible pathogenetic role of genes such as SHBG, CYP19A1, UGT2B15, and UGT2B17, and promising scientific directions. The available data indicate the need for a comprehensive study of not only anthropometric and biochemical indicators, but also hormonal-genetic markers in the assessment of this disease in women of reproductive age.

---

References

1. Tacke F, va hammualliflar. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology. 2024.

2. Jancova P, va hammualliflar. Relationship between MASLD and women's health: A review. 2025.

3. Weiskirchen R, va hammualliflar. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025.

4. Kasarinaite A, va hammualliflar. The Influence of Sex Hormones in Liver Function and Disease. 2023.

5. Fernández-Alonso AM, va hammualliflar. Nonalcoholic fatty liver disease risk in polycystic ovary syndrome. 2024.

6. Xu Q, va hammualliflar. Association of metabolic-dysfunction associated steatotic liver disease and polycystic ovary syndrome. 2024.

7. Di Stasi V, va hammualliflar. SHBG as a marker of NAFLD and metabolic impairments in women with PCOS. 2021.

8. Association Between Low Sex Hormone–Binding Globulin and Liver Fat. Diabetes. 2024.

9. Xing C, va hammualliflar. The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in PCOS Susceptibility: A Systematic Review and Meta-Analysis. 2022.

10. Sarfstein R, va hammualliflar. Identification of UDP-Glucuronosyltransferase 2B15 and 2B17 roles in steroid metabolism. 2022.

11. Bhatt DK, va hammualliflar. Hepatic abundance and activity of androgen- and drug-metabolizing enzyme UGT2B17 are associated with genotype, age, and sex. 2018.

12. Rouleau M, va hammualliflar. The liver proteome of individuals with a natural UGT2B17 deficiency. 2025.